Literature DB >> 19057004

Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise.

P W Bodell1, E Kodesh, F Haddad, F P Zaldivar, D M Cooper, G R Adams.   

Abstract

Childhood diseases are often accompanied by chronic inflammation, which is thought to negatively impact growth. Interleukin-6 (IL-6) is typically cited as an indicator of inflammation and is linked to impaired growth. This study was designed to isolate and identify potential effects of chronic IL-6 exposure on skeletal muscle growth during development. A second aim was to determine if endurance exercise, thought to antagonize chronic inflammation, would interact with any effects of IL-6. The muscles of one leg of rapidly growing rats were exposed to IL-6 or vehicle for 14 days. Subgroups of IL-6-infused rats were provided access to running wheels. Local IL-6 infusion resulted in approximately 13% muscle growth deficit (myofibrillar protein levels). Exercise (>4,000 m/day) prevented this deficit. IL-6 infusion increased mRNA for suppressor of cytokine signaling-3 (SOCS3) and tumor necrosis factor-alpha (TNF-alpha), and this was not prevented by exercise. IL-6 infusion increased the mRNAs for atrogin, insulin-like growth factor-I (IGF-I), and IGF binding protein-4 (IGFBP4), and these effects were mitigated by exercise. Exercise stimulated an increase in total RNA ( approximately 19%) only in the IL-6-infused muscle, suggesting that a compensatory increase in translational capacity was required to maintain muscle growth. This study indicates that IL-6 exposure during periods of rapid growth in young animals can retard growth possibly via interactions with key growth factors. Relatively high volumes of endurance-type exercise do not exacerbate the negative effects of IL-6 and in fact were found to be beneficial in protecting muscle growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057004      PMCID: PMC2644243          DOI: 10.1152/japplphysiol.90831.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  86 in total

1.  Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise.

Authors:  T Garma; C Kobayashi; F Haddad; G R Adams; P W Bodell; K M Baldwin
Journal:  J Appl Physiol (1985)       Date:  2006-09-28

2.  Determination of serum proteins by means of the biuret reaction.

Authors:  A G GORNALL; C J BARDAWILL; M M DAVID
Journal:  J Biol Chem       Date:  1949-02       Impact factor: 5.157

3.  Adrenomedullin and adrenomedullin-binding protein-1 downregulate inflammatory cytokines and attenuate tissue injury after gut ischemia-reperfusion.

Authors:  Gonzalo J Carrizo; Rongqian Wu; Xiaoxuan Cui; Amit J Dwivedi; H Hank Simms; Ping Wang
Journal:  Surgery       Date:  2006-09-14       Impact factor: 3.982

Review 4.  Effects of growth hormone on glucose and fat metabolism in human subjects.

Authors:  Jens O L Jørgensen; Louise Møller; Morten Krag; Nils Billestrup; Jens S Christiansen
Journal:  Endocrinol Metab Clin North Am       Date:  2007-03       Impact factor: 4.741

5.  Combined isometric, concentric, and eccentric resistance exercise prevents unloading-induced muscle atrophy in rats.

Authors:  G R Adams; F Haddad; P W Bodell; P D Tran; K M Baldwin
Journal:  J Appl Physiol (1985)       Date:  2007-09-13

Review 6.  IL-6 signalling in exercise and disease.

Authors:  B K Pedersen
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

7.  Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.

Authors:  T Levälampi; V Honkanen; P Lahdenne; R Nieminen; M Hakala; E Moilanen
Journal:  Scand J Rheumatol       Date:  2007 May-Jun       Impact factor: 3.641

8.  Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle.

Authors:  Stephan Glund; Atul Deshmukh; Yun Chau Long; Theodore Moller; Heikki A Koistinen; Kenneth Caidahl; Juleen R Zierath; Anna Krook
Journal:  Diabetes       Date:  2007-03-15       Impact factor: 9.461

9.  Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.

Authors:  Stuart L Goldstein; Jocelyn C Leung; Douglas M Silverstein
Journal:  Clin J Am Soc Nephrol       Date:  2006-08-16       Impact factor: 8.237

10.  Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis.

Authors:  Ana Paola N Lotito; Ana Campa; Clovis A A Silva; Maria H B Kiss; Suzana B V Mello
Journal:  J Rheumatol       Date:  2007-03-01       Impact factor: 4.666

View more
  29 in total

1.  Inflammation and mortality in a frail mouse model.

Authors:  Fred Ko; Qilu Yu; Qian-Li Xue; Wenliang Yao; Cory Brayton; Huanle Yang; Neal Fedarko; Jeremy Walston
Journal:  Age (Dordr)       Date:  2011-06-02

Review 2.  Interleukin 6 as a key regulator of muscle mass during cachexia.

Authors:  James A Carson; Kristen A Baltgalvis
Journal:  Exerc Sport Sci Rev       Date:  2010-10       Impact factor: 6.230

3.  Influenza A Virus Infection Induces Muscle Wasting via IL-6 Regulation of the E3 Ubiquitin Ligase Atrogin-1.

Authors:  Kathryn A Radigan; Trevor T Nicholson; Lynn C Welch; Monica Chi; Luciano Amarelle; Martín Angulo; Masahiko Shigemura; Atsuko Shigemura; Constance E Runyan; Luisa Morales-Nebreda; Harris Perlman; Ermelinda Ceco; Emilia Lecuona; Laura A Dada; Alexander V Misharin; Gokhan M Mutlu; Jacob I Sznajder; G R Scott Budinger
Journal:  J Immunol       Date:  2018-12-07       Impact factor: 5.422

4.  Prostaglandin E2 induces transcription of skeletal muscle mass regulators interleukin-6 and muscle RING finger-1 in humans.

Authors:  R A Standley; S Z Liu; B Jemiolo; S W Trappe; T A Trappe
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-03-13       Impact factor: 4.006

5.  Prostaglandin and myokine involvement in the cyclooxygenase-inhibiting drug enhancement of skeletal muscle adaptations to resistance exercise in older adults.

Authors:  Todd A Trappe; Robert A Standley; Bozena Jemiolo; Chad C Carroll; Scott W Trappe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-05       Impact factor: 3.619

6.  Differential genomic responses in old vs. young humans despite similar levels of modest muscle damage after resistance loading.

Authors:  Anna E Thalacker-Mercer; Louis J Dell'Italia; Xiangqin Cui; James M Cross; Marcas M Bamman
Journal:  Physiol Genomics       Date:  2009-11-10       Impact factor: 3.107

7.  Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.

Authors:  James P White; Melissa J Puppa; Song Gao; Shuichi Sato; Stephen L Welle; James A Carson
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-26       Impact factor: 4.310

8.  Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans.

Authors:  Edward K Merritt; Michael J Stec; Anna Thalacker-Mercer; Samuel T Windham; James M Cross; David P Shelley; S Craig Tuggle; David J Kosek; Jeong-Su Kim; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2013-05-16

9.  Heightened TWEAK-NF-κB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury.

Authors:  Ceren Yarar-Fisher; C Scott Bickel; Neil A Kelly; Michael J Stec; Samuel T Windham; Amie B McLain; Robert A Oster; Marcas M Bamman
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-01       Impact factor: 4.310

10.  Elevated SOCS3 and altered IL-6 signaling is associated with age-related human muscle stem cell dysfunction.

Authors:  Bryon R McKay; Daniel I Ogborn; Jeff M Baker; Kyle G Toth; Mark A Tarnopolsky; Gianni Parise
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-07       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.